NASDAQ : PRQR
ProQR Therapeutics N.V. — Financial statements
Healthcare · Biotechnology · Netherlands
Last price 1.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 203.21M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
ProQR Therapeutics N.V. (PRQR) reported revenue of 18.42M EUR (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 18.36M | 15.91M | 18.91M | 6.51M | 3.59M | 1.33M |
| Other Revenue | 61.00K | 441.00K | 640.00K | 80.00K | 765.00K | 1.04M |
| Revenue | 18.42M | 16.35M | 19.55M | 6.59M | 4.36M | 2.38M |
| Gross Profit | 18.42M | 16.35M | 19.55M | 6.59M | 4.36M | 2.38M |
| Selling, General & Admin | 15.78M | 15.06M | 13.66M | 16.24M | 18.65M | 17.37M |
| Research & Development | 45.50M | 44.73M | 36.36M | 25.15M | 50.87M | 42.22M |
| Operating Expenses | 61.27M | 59.79M | 50.02M | 41.38M | 69.52M | 59.59M |
| Operating Income | -42.85M | -43.45M | -30.47M | -34.79M | -65.16M | -57.21M |
| Interest Expense | -929.00K | -929.00K | -1.08M | -1.20M | -5.13M | -3.40M |
| Interest & Investment Income | 2.05M | 2.33M | 3.25M | 2.59M | 106.00K | 5.00K |
| Earnings From Equity Investments | -8.00K | -217.00K | ||||
| Currency Exchange Gain (Loss) | -358.00K | -358.00K | -7.00K | -255.00K | 4.76M | 1.51M |
| Other Non Operating Income (Expenses) | 78.00K | 235.00K | 345.00K | 953.00K | 2.71M | -1.88M |
| EBT Excluding Unusual Items | -42.01M | -42.16M | -27.96M | -32.70M | -62.72M | -61.20M |
| Gain (Loss) on Sale of Investments | 514.00K | |||||
| Gain (Loss) on Sale of Assets | 3.02M | |||||
| Other Unusual Items | 1.87M | -1.39M | ||||
| Pretax Income | -42.01M | -42.16M | -27.96M | -27.81M | -64.11M | -60.68M |
| Income Tax Expense | 26.00K | 19.00K | -197.00K | -78.00K | 96.00K | 117.00K |
| Earnings From Continuing Operations | -42.04M | -42.18M | -27.76M | -27.73M | -64.20M | -60.80M |
| Minority Interest in Earnings | -384.00K | -220.00K | 59.00K | |||
| Net Income | -42.04M | -42.18M | -27.76M | -28.12M | -64.42M | -60.74M |
| Net Income to Common | -42.04M | -42.18M | -27.76M | -28.12M | -64.42M | -60.74M |
| Shares Outstanding (Basic) | 106.51M | 105.33M | 86.09M | 81.01M | 71.64M | 64.18M |
| Shares Outstanding (Diluted) | 106.51M | 105.33M | 86.09M | 81.01M | 71.64M | 64.18M |
| EPS (Basic) | -0.39 | -0.40 | -0.32 | -0.35 | -0.90 | -0.95 |
| EPS (Diluted) | -0.40 | -0.40 | -0.32 | -0.35 | -0.90 | -0.95 |
| Free Cash Flow | -50.16M | -53.81M | -37.81M | 20.18M | -69.22M | -26.50M |
| Free Cash Flow Per Share | -0.47 | -0.51 | -0.44 | 0.25 | -0.97 | -0.41 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -232.60% | -265.77% | -155.91% | -527.60% | -1,494.82% | -2,405.80% |
| Profit Margin | -228.18% | -258.05% | -142.05% | -426.43% | -1,477.95% | -2,554.25% |
| Free Cash Flow Margin | -272.25% | -329.18% | -193.46% | 305.99% | -1,587.89% | -1,114.21% |
| EBITDA | -41.90M | -42.54M | -29.58M | -34.11M | -64.38M | -56.55M |
| EBITDA Margin | -227.44% | -260.26% | -151.33% | |||
| D&A For EBITDA | 950.00K | 902.00K | 894.00K | 680.00K | 784.00K | 657.00K |
| EBIT | -42.85M | -43.45M | -30.47M | -34.79M | -65.16M | -57.21M |
| EBIT Margin | -232.60% | -265.77% | -155.91% |
Balance sheet
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 117.12M | 92.41M | 149.41M | 118.92M | 94.78M | 187.52M |
| Cash & Short-Term Investments | 117.12M | 92.41M | 149.41M | 118.92M | 94.78M | 187.52M |
| Accounts Receivable | 56.25M | |||||
| Other Receivables | 1.86M | 5.09M | 2.03M | 1.27M | 982.00K | 823.00K |
| Receivables | 1.86M | 5.09M | 2.03M | 1.27M | 57.24M | 823.00K |
| Prepaid Expenses | 2.65M | 2.63M | 2.41M | 793.00K | 2.45M | 3.14M |
| Total Current Assets | 121.63M | 100.13M | 153.84M | 120.99M | 154.46M | 191.48M |
| Property, Plant & Equipment | 11.92M | 12.63M | 14.11M | 16.90M | 16.24M | 17.47M |
| Long-Term Investments | 621.00K | 629.00K | ||||
| Total Assets | 133.55M | 112.76M | 167.96M | 137.88M | 171.32M | 209.58M |
| Accounts Payable | 298.00K | 16.00K | 1.54M | 392.00K | 191.00K | |
| Accrued Expenses | 214.00K | 1.48M | 1.66M | 1.12M | 1.23M | |
| Current Portion of Long-Term Debt | 5.02M | 4.87M | 4.58M | 2.50M | 4.77M | |
| Current Portion of Leases | 1.60M | 1.54M | 1.57M | 1.61M | 1.39M | 1.53M |
| Current Unearned Revenue | 17.64M | 17.55M | 21.94M | 20.57M | 5.64M | 5.12M |
| Other Current Liabilities | 10.40M | 8.17M | 9.32M | 8.82M | 9.95M | 14.76M |
| Total Current Liabilities | 34.87M | 32.44M | 38.90M | 34.20M | 20.99M | 27.60M |
| Long-Term Debt | 4.29M | 4.27M | 39.32M | |||
| Long-Term Leases | 8.69M | 9.55M | 11.07M | 13.83M | 13.81M | 14.75M |
| Long-Term Unearned Revenue | 10.51M | 21.39M | 29.43M | 44.17M | 65.57M | 14.69M |
| Total Liabilities | 54.08M | 63.38M | 79.40M | 96.49M | 104.64M | 96.35M |
| Common Stock | 5.74M | 4.31M | 4.31M | 3.37M | 3.37M | 3.00M |
| Additional Paid-In Capital | 531.65M | 483.88M | 483.81M | 412.89M | 412.54M | 398.31M |
| Retained Earnings | -487.41M | -467.51M | -427.16M | -400.85M | -379.11M | -317.77M |
| Comprehensive Income & Other | 29.50M | 28.69M | 27.60M | 25.98M | 30.26M | 30.30M |
| Total Common Equity | 79.48M | 49.37M | 88.56M | 41.39M | 67.06M | 113.83M |
| Minority Interest | -384.00K | -604.00K | ||||
| Shareholders' Equity | 79.48M | 49.37M | 88.56M | 41.39M | 66.68M | 113.23M |
| Total Liabilities & Equity | 133.55M | 112.76M | 167.96M | 137.88M | 171.32M | 209.58M |
| Total Debt | 15.31M | 15.96M | 17.22M | 19.73M | 21.97M | 60.37M |
| Net Cash (Debt) | 101.81M | 76.45M | 132.19M | 99.19M | 72.80M | 127.15M |
| Net Cash Per Share | 0.96 | 0.73 | 1.54 | 1.22 | 1.02 | 1.98 |
| Filing Date Shares Outstanding | 141.12M | 105.36M | 105.21M | 81.35M | 80.82M | 71.29M |
| Total Common Shares Outstanding | 141.12M | 105.36M | 105.21M | 81.35M | 80.82M | 71.29M |
| Working Capital | 86.76M | 67.69M | 114.94M | 86.78M | 133.47M | 163.89M |
| Book Value Per Share | 0.56 | 0.47 | 0.84 | 0.51 | 0.83 | 1.60 |
| Tangible Book Value | 79.48M | 49.37M | 88.56M | 41.39M | 67.06M | 113.83M |
| Tangible Book Value Per Share | 0.56 | 0.47 | 0.84 | 0.51 | 0.83 | 1.60 |
| Buildings | 24.19M | 23.79M | 24.77M | 22.86M | 22.23M | |
| Machinery | 7.53M | 6.82M | 5.91M | 4.91M | 4.25M |
Cash flow statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -42.04M | -42.18M | -27.76M | -28.12M | -64.42M | -60.74M |
| Depreciation & Amortization | 2.75M | 2.70M | 2.76M | 2.51M | 2.52M | 2.33M |
| Loss (Gain) From Sale of Assets | -131.00K | |||||
| Loss (Gain) From Sale of Investments | -514.00K | |||||
| Loss (Gain) on Equity Investments | 8.00K | 217.00K | ||||
| Stock-Based Compensation | 5.13M | 4.01M | 2.54M | 3.11M | 2.87M | 6.22M |
| Other Operating Activities | 308.00K | 93.00K | -671.00K | -4.78M | -4.49M | 1.47M |
| Change in Unearned Revenue | -11.98M | -11.98M | -12.73M | -6.47M | -2.99M | |
| Change in Other Net Operating Assets | -3.18M | -5.43M | -536.00K | 55.43M | -2.00M | 25.01M |
| Operating Cash Flow | -49.01M | -52.79M | -36.39M | 21.55M | -68.51M | -26.01M |
| Capital Expenditures | -1.15M | -1.02M | -1.42M | -1.37M | -708.00K | -484.00K |
| Sale of Property, Plant & Equipment | 60.00K | 6.00K | 59.00K | |||
| Sale (Purchase) of Intangibles | 7.94M | |||||
| Other Investing Activities | -2.65M | -2.35M | ||||
| Investing Cash Flow | -1.15M | -1.02M | -4.07M | 4.28M | -702.00K | -425.00K |
| Long-Term Debt Issued | 27.66M | |||||
| Long-Term Debt Repaid | -1.91M | -1.58M | -2.63M | -45.05M | -820.00K | |
| Lease Payments | -1.97M | -1.91M | -1.58M | -1.62M | -1.67M | -820.00K |
| Net Debt Issued (Repaid) | -1.97M | -1.91M | -1.58M | -2.63M | -45.05M | 26.84M |
| Issuance of Common Stock | 49.20M | 69.00K | 71.86M | 354.00K | 14.16M | 110.00M |
| Financing Cash Flow | 47.23M | -1.84M | 70.28M | -2.27M | -30.89M | 136.83M |
| Foreign Exchange Rate Adjustments | 284.00K | -1.35M | 673.00K | 599.00K | 7.35M | 1.29M |
| Net Cash Flow | -2.64M | -56.99M | 30.48M | 24.15M | -92.75M | 111.69M |
| Free Cash Flow | -50.16M | -53.81M | -37.81M | 20.18M | -69.22M | -26.50M |
| Free Cash Flow Margin | -272.25% | -329.18% | -193.46% | 305.99% | -1,587.89% | -1,114.21% |
| Free Cash Flow Per Share | -0.47 | -0.51 | -0.44 | 0.25 | -0.97 | -0.41 |
| Levered Free Cash Flow | -19.07M | -32.04M | -18.04M | 62.80M | -99.16M | -16.21M |
| Unlevered Free Cash Flow | -18.49M | -31.46M | -17.37M | 63.56M | -95.96M | -14.09M |
| Free Cash Flow After Leases | -52.13M | -55.72M | -39.39M | 18.56M | -70.89M | -27.32M |
| Cash Interest Paid | 439.00K | 518.00K | 770.00K | 789.00K | 3.76M | 2.25M |
| Cash Income Tax Paid | 26.00K | 19.00K | -197.00K | -78.00K | 96.00K | 117.00K |
| Change in Working Capital | -15.16M | -17.42M | -13.26M | 48.96M | -4.99M | 25.01M |
Ratios
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 194.75M | 212.80M | 273.49M | 160.69M | 264.31M | 569.95M |
| Enterprise Value | 78.43M | 106.74M | 193.18M | 55.61M | 187.24M | 429.80M |
| Last Close Price | 1.39 | 2.02 | 2.65 | 1.98 | 3.70 | 8.01 |
| PS Ratio | 9.22 | 11.09 | 13.52 | 22.05 | 56.74 | 210.75 |
| PB Ratio | 2.16 | 3.67 | 2.98 | 3.51 | 3.71 | 4.43 |
| P/TBV Ratio | 2.14 | 3.67 | 2.98 | 3.51 | 3.69 | 4.40 |
| P/FCF Ratio | 7.21 | |||||
| P/OCF Ratio | 6.75 | |||||
| EV/Sales Ratio | 3.69 | 5.56 | 9.55 | 7.63 | 40.19 | 158.93 |
| EV/FCF Ratio | 2.49 | |||||
| Debt / Equity Ratio | 0.19 | 0.32 | 0.19 | 0.48 | 0.33 | 0.53 |
| Debt / FCF Ratio | 0.98 | |||||
| Net Debt / Equity Ratio | -1.28 | -1.55 | -1.49 | -2.40 | -1.09 | -1.12 |
| Net Debt / EBITDA Ratio | 2.43 | 1.80 | 4.47 | 2.91 | 1.13 | 2.25 |
| Net Debt / FCF Ratio | 2.03 | 1.42 | 3.50 | -4.92 | 1.05 | 4.80 |
| Asset Turnover | 0.14 | 0.12 | 0.13 | 0.04 | 0.02 | 0.01 |
| Quick Ratio | 3.41 | 3.00 | 3.89 | 3.51 | 7.24 | 6.83 |
| Current Ratio | 3.49 | 3.09 | 3.96 | 3.54 | 7.36 | 6.94 |
| Return on Equity (ROE) | -57.40% | -61.17% | -42.73% | -51.33% | -71.37% | -71.62% |
| Return on Assets (ROA) | -19.76% | -19.35% | -12.45% | -14.06% | -21.38% | -23.20% |
| Return on Capital Employed (ROCE) | -43.40% | -54.10% | -23.60% | -33.60% | -43.30% | -31.40% |
| Earnings Yield | -33.17% | -23.28% | -10.51% | -19.34% | -26.05% | -12.12% |
| FCF Yield | -28.99% | -29.69% | -14.31% | 13.88% | -27.99% | -5.29% |
| Buyback Yield / Dilution | -8.75% | -22.36% | -6.26% | -13.08% | -11.62% | -28.21% |